These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14645665)

  • 1. A new and simple method for delivering clamped nitric oxide concentrations in the physiological range: application to activation of guanylyl cyclase-coupled nitric oxide receptors.
    Griffiths C; Wykes V; Bellamy TC; Garthwaite J
    Mol Pharmacol; 2003 Dec; 64(6):1349-56. PubMed ID: 14645665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
    Severina IS
    Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of guanylyl cyclase and mitochondrial respiration to nitric oxide measured using clamped concentrations.
    Bellamy TC; Griffiths C; Garthwaite J
    J Biol Chem; 2002 Aug; 277(35):31801-7. PubMed ID: 12080082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
    Bellingham M; Evans TJ
    Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of NO-activated guanylyl cyclases expressed in cells.
    Gibb BJ; Wykes V; Garthwaite J
    Br J Pharmacol; 2003 Jul; 139(5):1032-40. PubMed ID: 12839878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide photogeneration from trans-Cr(cyclam)(ONO)(2)(+) in a reducing environment. activation of soluble guanylyl cyclase and arterial vasorelaxation.
    Ostrowski AD; Deakin SJ; Azhar B; Miller TW; Franco N; Cherney MM; Lee AJ; Burstyn JN; Fukuto JM; Megson IL; Ford PC
    J Med Chem; 2010 Jan; 53(2):715-22. PubMed ID: 19950902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
    Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
    Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin mediated nitrite activation of soluble guanylyl cyclase.
    Jeffers A; Xu X; Huang KT; Cho M; Hogg N; Patel RP; Kim-Shapiro DB
    Comp Biochem Physiol A Mol Integr Physiol; 2005 Oct; 142(2):130-5. PubMed ID: 15936233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of nitric oxide and soluble guanylyl cyclase.
    Krumenacker JS; Hanafy KA; Murad F
    Brain Res Bull; 2004 Feb; 62(6):505-15. PubMed ID: 15036565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
    Reyna-Neyra A; Sarkar G; Etgen AM
    J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
    Hanke CJ; Drewett JG; Myers CR; Campbell WB
    Endocrinology; 1998 Oct; 139(10):4053-60. PubMed ID: 9751482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-sensitive guanylyl cyclase: structure and regulation.
    Koesling D; Russwurm M; Mergia E; Mullershausen F; Friebe A
    Neurochem Int; 2004 Nov; 45(6):813-9. PubMed ID: 15312975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the soluble guanylate cyclase pathway the only one available for nitric oxide (NO) signaling?
    Landar A; Darley-Usmar VM
    IUBMB Life; 2007 Feb; 59(2):110-2. PubMed ID: 17454303
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of nitric oxide-sensitive guanylyl cyclase.
    Friebe A; Koesling D
    Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines].
    Severina IS; Piatakova NV; Shchegolev AIu
    Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation.
    Kajiya K; Huggenberger R; Drinnenberg I; Ma B; Detmar M
    FASEB J; 2008 Feb; 22(2):530-7. PubMed ID: 17855621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shaping of nitric oxide signals by a cellular sink.
    Griffiths C; Garthwaite J
    J Physiol; 2001 Nov; 536(Pt 3):855-62. PubMed ID: 11691877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble guanylyl cyclase: the nitric oxide receptor.
    Martin E; Berka V; Tsai AL; Murad F
    Methods Enzymol; 2005; 396():478-92. PubMed ID: 16291255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.